Yatiri Bio Secures Exclusive Option For Denfivontinib In AML
24 Mar 2026 //
GLOBENEWSWIRE
USFDA grants ODD to Cevidoplenib for immune thrombocytopenia
23 Mar 2024 //
INDIANPHARMAPOST
FDA Grants Orphan Drug Designation to Cevidoplenib for ITP
21 Mar 2024 //
PR NEWSWIRE
Oscotec/ADEL Initiates Dosing in Ph1 of Anti-MTBR Tau Antibody ADEL-Y01
23 Feb 2024 //
PR NEWSWIRE
Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01
14 Sep 2023 //
PR NEWSWIRE

Market Place
Sourcing Support